TRAIL receptor agonists

TRAIL receptor agonists are therapies designed to activate specific proteins called TRAIL receptors on the surface of cells. When these receptors are stimulated, they can trigger the process of programmed cell death (apoptosis), which is a natural way the body eliminates unhealthy or cancerous cells. This targeted approach aims to selectively destroy cancer cells while sparing normal cells, making TRAIL receptor agonists a promising option for cancer treatment. Researchers are exploring these agents because they can induce cancer cell death through a mechanism that minimizes damage to healthy tissue.